These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 34410317)

  • 1. Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease.
    Lobanova E; Whiten D; Ruggeri FS; Taylor CG; Kouli A; Xia Z; Emin D; Zhang YP; Lam JYL; Williams-Gray CH; Klenerman D
    Brain; 2022 Apr; 145(2):632-643. PubMed ID: 34410317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Protein Aggregates in Parkinson's Disease Serum Using Aptamer-Assisted Single-Molecule Pull-Down.
    Zhang YP; Lobanova E; Emin D; Lobanov SV; Kouli A; Williams-Gray CH; Klenerman D
    Anal Chem; 2023 Oct; 95(41):15254-15263. PubMed ID: 37782556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers.
    Sanchez SE; Whiten DR; Meisl G; Ruggeri FS; Hidari E; Klenerman D
    Chembiochem; 2021 Oct; 22(19):2867-2871. PubMed ID: 34383993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
    Compta Y; Revesz T
    J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells.
    Whiten DR; Zuo Y; Calo L; Choi ML; De S; Flagmeier P; Wirthensohn DC; Kundel F; Ranasinghe RT; Sanchez SE; Athauda D; Lee SF; Dobson CM; Gandhi S; Spillantini MG; Klenerman D; Horrocks MH
    Chembiochem; 2018 Oct; 19(19):2033-2038. PubMed ID: 30051958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative super-resolution imaging of pathological aggregates reveals distinct toxicity profiles in different synucleinopathies.
    Morten MJ; Sirvio L; Rupawala H; Mee Hayes E; Franco A; Radulescu C; Ying L; Barnes SJ; Muga A; Ye Y
    Proc Natl Acad Sci U S A; 2022 Oct; 119(41):e2205591119. PubMed ID: 36206368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Molecule Counting Coupled to Rapid Amplification Enables Detection of α-Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients.
    Bhumkar A; Magnan C; Lau D; Jun ESW; Dzamko N; Gambin Y; Sierecki E
    Angew Chem Int Ed Engl; 2021 May; 60(21):11874-11883. PubMed ID: 33511725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-molecule characterization of salivary protein aggregates from Parkinson's disease patients: a pilot study.
    Furlepa M; Zhang YP; Lobanova E; Kahanawita L; Vivacqua G; Williams-Gray CH; Klenerman D
    Brain Commun; 2024; 6(3):fcae178. PubMed ID: 38863577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease.
    Emin D; Zhang YP; Lobanova E; Miller A; Li X; Xia Z; Dakin H; Sideris DI; Lam JYL; Ranasinghe RT; Kouli A; Zhao Y; De S; Knowles TPJ; Vendruscolo M; Ruggeri FS; Aigbirhio FI; Williams-Gray CH; Klenerman D
    Nat Commun; 2022 Sep; 13(1):5512. PubMed ID: 36127374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
    Goldman JG; Andrews H; Amara A; Naito A; Alcalay RN; Shaw LM; Taylor P; Xie T; Tuite P; Henchcliffe C; Hogarth P; Frank S; Saint-Hilaire MH; Frasier M; Arnedo V; Reimer AN; Sutherland M; Swanson-Fischer C; Gwinn K; ; Kang UJ
    Mov Disord; 2018 Feb; 33(2):282-288. PubMed ID: 29205509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
    Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
    J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Molecule Detection of α-Synuclein Oligomers in Parkinson's Disease Patients Using Nanopores.
    Liu Y; Wang X; Campolo G; Teng X; Ying L; Edel JB; Ivanov AP
    ACS Nano; 2023 Nov; 17(22):22999-23009. PubMed ID: 37947369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates.
    Watanabe H; Ono M; Ariyoshi T; Katayanagi R; Saji H
    ACS Chem Neurosci; 2017 Aug; 8(8):1656-1662. PubMed ID: 28467708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids.
    Horrocks MH; Lee SF; Gandhi S; Magdalinou NK; Chen SW; Devine MJ; Tosatto L; Kjaergaard M; Beckwith JS; Zetterberg H; Iljina M; Cremades N; Dobson CM; Wood NW; Klenerman D
    ACS Chem Neurosci; 2016 Mar; 7(3):399-406. PubMed ID: 26800462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Innate Host Defense Protein β
    Rani K; Pal A; Gurnani B; Agarwala P; Sasmal DK; Jain N
    J Mol Biol; 2023 Nov; 435(22):168285. PubMed ID: 37741548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
    Katayama T; Sawada J; Kikuchi-Takeguchi S; Kano K; Takahashi K; Saito T; Okizaki A; Hasebe N
    Neurosci Lett; 2020 Jan; 715():134564. PubMed ID: 31733322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.